Site of subcutaneous desferrioxamine injection is the initial site of post-transfusion urticaria in multi-transfused beta-thalassaemia major patients.
Daar
S
S
Ghosh
K
K
Nirmala
V
V
D000293:Adolescent; D000328:Adult; D002614:Chelating Agents / Q000008:administration & dosage / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003676:Deferoxamine / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D007279:Injections, Subcutaneous / Q000009:adverse effects; D013156:Splenectomy; D065227:Transfusion Reaction; D014581:Urticaria / Q000139:chemically induced*; D017086:beta-Thalassemia / Q000628:therapy*
D002614:Chelating Agents; D003676:Deferoxamine